Block Listing Interim Review

2025-11-04 11:46:36

(MENAFN- GlobeNewsWire - Nasdaq) BLOCK LISTING SIX MONTHLY RETURN

(Note: Italicised terms have the same meaning as given in the UK Listing Rules.)

Date: 4 November 2025

Name of applicant:	PayPoint plc
Name of scheme:	a. PayPoint plc Share Incentive Plan b. PayPoint plc Deferred Bonus Plan c. PayPoint plc Long Term Incentive Plan d. PayPoint Executive Share Plan (previously named PayPoint Restricted Share Plan)
Period of return:	From:	26 April 2025	To:	31 October 2025
Balance of unallotted securities under scheme(s) from previous return:	342,815 ordinary shares of 1/3p each 223,825 ordinary shares of 1/3p each 157,903 ordinary shares of 1/3p each 163,399 ordinary shares of 1/3p each
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	Nil Nil Nil Nil
Less: Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G)	4,821 ordinary shares of 1/3p each 22,101 Nil 78,040 ordinary shares of 1/3p each
Equals: Balance under scheme(s) not yet issued/allotted at end of period:	337,994 ordinary shares of 1/3p each 201,724 ordinary shares of 1/3p each 157,903 ordinary shares of 1/3p each 85,359 ordinary shares of 1/3p each POST CONSOLIDATION FIGURES: (New Shares = Existing Shares x 12/13) 311,994 186,206 145,756 78,792
Notes	PayPoint plc underwent a consolidation of share capital on 17 October 2025 on the basis of 12 new ordinary shares for every 13 existing ordinary shares held, resulting in a new nominal value of 0.3611 pence per share (previously 0.3333 pence).

Enquiries:

PayPoint Plc
Phil Higgins, on behalf of Indigo Corporate Secretary Limited, Company Secretary
+44 (0)7707 061 533

LEI: 5493004YKWI8U0GDD138

-ends-

MENAFN04112025004107003653ID1110294098

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.